16-3966354-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001116.4(ADCY9):c.3483C>T(p.Phe1161=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00209 in 1,614,108 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 26 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 31 hom. )
Consequence
ADCY9
NM_001116.4 synonymous
NM_001116.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.713
Genes affected
ADCY9 (HGNC:240): (adenylate cyclase 9) Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. It is regulated by a family of G protein-coupled receptors, protein kinases, and calcium. The type 9 adenylyl cyclase is a widely distributed adenylyl cyclase, and it is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, calcium, and somatostatin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 16-3966354-G-A is Benign according to our data. Variant chr16-3966354-G-A is described in ClinVar as [Benign]. Clinvar id is 768749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.713 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0116 (1764/152296) while in subpopulation AFR AF= 0.0405 (1684/41550). AF 95% confidence interval is 0.0389. There are 26 homozygotes in gnomad4. There are 814 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1764 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADCY9 | NM_001116.4 | c.3483C>T | p.Phe1161= | synonymous_variant | 11/11 | ENST00000294016.8 | |
ADCY9 | XM_005255079.4 | c.3540C>T | p.Phe1180= | synonymous_variant | 11/11 | ||
ADCY9 | XM_011522353.3 | c.2927+8315C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADCY9 | ENST00000294016.8 | c.3483C>T | p.Phe1161= | synonymous_variant | 11/11 | 1 | NM_001116.4 | P1 | |
ADCY9 | ENST00000576936.5 | c.567+8315C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0116 AC: 1758AN: 152178Hom.: 26 Cov.: 33
GnomAD3 genomes
AF:
AC:
1758
AN:
152178
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00305 AC: 764AN: 250718Hom.: 10 AF XY: 0.00224 AC XY: 303AN XY: 135546
GnomAD3 exomes
AF:
AC:
764
AN:
250718
Hom.:
AF XY:
AC XY:
303
AN XY:
135546
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1606AN: 1461812Hom.: 31 Cov.: 33 AF XY: 0.000913 AC XY: 664AN XY: 727204
GnomAD4 exome
AF:
AC:
1606
AN:
1461812
Hom.:
Cov.:
33
AF XY:
AC XY:
664
AN XY:
727204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0116 AC: 1764AN: 152296Hom.: 26 Cov.: 33 AF XY: 0.0109 AC XY: 814AN XY: 74484
GnomAD4 genome
AF:
AC:
1764
AN:
152296
Hom.:
Cov.:
33
AF XY:
AC XY:
814
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at